- A Brief Overview.
作者信息
Gill Gurmat Kaur, Gill Jaskirat Kaur, Thakur Suman, Galwankar Sagar, Gill Harman Singh
机构信息
Department of Infectious Disease and Internal Medicine, Division of Infectious Disease, University at Buffalo, Buffalo, New York, NY, USA.
Department of Emergency Medicine, Institute of Critical Care Medicine, Mount Sinai Health System, New York, NY, USA.
出版信息
J Glob Infect Dis. 2024 Mar 18;16(1):3-4. doi: 10.4103/jgid.jgid_52_24. eCollection 2024 Jan-Mar.
Abstract
摘要
相似文献
1
- A Brief Overview.- 简要概述。
J Glob Infect Dis. 2024 Mar 18;16(1):3-4. doi: 10.4103/jgid.jgid_52_24. eCollection 2024 Jan-Mar.
2
: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen.如何筛查、检测、测试及控制这种新出现病原体的概述。
Antibiotics (Basel). 2020 Nov 5;9(11):778. doi: 10.3390/antibiotics9110778.
3
A description of the first Candida auris-colonized individuals in New York State, 2016-2017.2016-2017 年纽约州首例耳念珠菌定植个体的描述。
Am J Infect Control. 2022 Mar;50(3):358-360. doi: 10.1016/j.ajic.2021.10.037. Epub 2021 Nov 15.
4
Overview about Candida auris: What's up 12 years after its first description?关于耳念珠菌的概述：首次描述 12 年后的最新情况
J Mycol Med. 2022 May;32(2):101248. doi: 10.1016/j.mycmed.2022.101248. Epub 2022 Jan 21.
5
High-Throughput Profiling of Candida auris Isolates Reveals Clade-Specific Metabolic Differences.高通量分析揭示了耳念珠菌分离株的特定进化枝代谢差异。
Microbiol Spectr. 2023 Jun 15;11(3):e0049823. doi: 10.1128/spectrum.00498-23. Epub 2023 Apr 25.
6
First case of infection in Belgium in a surgical patient from Kuwait.比利时首例感染病例为一名来自科威特的外科手术患者。
Acta Clin Belg. 2020 Jun;75(3):221-228. doi: 10.1080/17843286.2018.1555114. Epub 2018 Dec 4.
7
: An Overview of the Emerging Drug-Resistant Fungal Infection.新兴耐药真菌感染概述
Infect Chemother. 2022 Jun;54(2):236-246. doi: 10.3947/ic.2022.0008.
8
A rare fungus on the rise: .一种日益增多的罕见真菌：
Am J Health Syst Pharm. 2018 Jul 15;75(14):1013-1017. doi: 10.2146/ajhp170640. Epub 2018 Jun 12.
9
Modeling Candida auris Colonization on Porcine Skin Ex Vivo.体外模拟耳念珠菌在猪皮上的定植。
Methods Mol Biol. 2022;2517:251-258. doi: 10.1007/978-1-0716-2417-3_20.
10
An Overview on in Healthcare Settings.医疗环境概述。 （你提供的原文似乎不完整，“An Overview on in Healthcare Settings.” 这里中间少了具体内容）
J Fungi (Basel). 2023 Sep 8;9(9):913. doi: 10.3390/jof9090913.
本文引用的文献
1
State of The Globe: -A Global Healthcare Threat.全球状况：一种全球医疗威胁。
J Glob Infect Dis. 2022 Nov 30;14(4):129-130. doi: 10.4103/jgid.jgid_215_22. eCollection 2022 Oct-Dec.
2
Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of : A European Study.伊柏昔芬（SCY-078）对来自有医学相关性的曲霉菌属种的当代血培养分离株的抗真菌活性：一项欧洲研究。
Front Cell Infect Microbiol. 2022 May 16;12:906563. doi: 10.3389/fcimb.2022.906563. eCollection 2022.
3
Candida auris: a fungus with identity crisis.耳念珠菌：一种身份成谜的真菌。
Pathog Dis. 2020 Jun 1;78(4). doi: 10.1093/femspd/ftaa034.
4
Candida auris: a Review of the Literature.耳念珠菌：文献复习。
Clin Microbiol Rev. 2017 Nov 15;31(1). doi: 10.1128/CMR.00029-17. Print 2018 Jan.
5
Current perspective on emergence, diagnosis and drug resistance in .关于……的出现、诊断和耐药性的当前观点 。（原文表述不完整，翻译只能到这一步）
Infect Drug Resist. 2017 Jun 7;10:155-165. doi: 10.2147/IDR.S116229. eCollection 2017.
6
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.新兴病原体耳念珠菌：生长表型、毒力因子、抗真菌药物活性以及新型葡聚糖合成抑制剂SCY-078对生长形态和生物膜形成的影响
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02396-16. Print 2017 May.
7
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.高毒力、多重耐药耳念珠菌的生物膜形成能力
Emerg Infect Dis. 2017 Feb;23(2):328-331. doi: 10.3201/eid2302.161320.
8
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.《念珠菌病管理临床实践指南：美国传染病学会2016年更新版》
Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.
9
Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures.评价 MALDI-TOF-MS 方法在鉴定血培养分离的念珠菌菌株中的应用。
Diagn Microbiol Infect Dis. 2012 May;73(1):65-7. doi: 10.1016/j.diagmicrobio.2012.01.013.
10
Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature.棘白菌素类药物（阿尼芬净、卡泊芬净和米卡芬净）在侵袭性念珠菌病治疗中的药理学和代谢：文献复习。
Eur J Med Res. 2011 Apr 28;16(4):159-66. doi: 10.1186/2047-783x-16-4-159.
Zotero 插件